Name	Webedition CMS
Purpose	This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name	econda
Purpose	Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.

Name

Webedition CMS

Purpose

This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.

Name

econda

Purpose

Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.

Name	econda
Purpose	Statistics

Name

econda

Purpose

Statistics

Name	Youtube
Purpose	External media

Name

Youtube

Purpose

External media

Bridging Group Mechanisms of Leukemogenesis

PD Dr. Daniel Mertens

Inactivation of 13q14 in leukemic cells. Candidate genes in chromosomal band 13q14 are monoallelically expressed in non-malignant cells due to an epig
© dkfz.de

Cancer patients die from resistance to therapy and metastasis. These processes are based on genetic and epigenetic aberrations and require the support of the tumor microenvironment that supplies pro-survival and protective stimuli. Understanding the molecular mechanism of these processes will allow one to target aberrant (epi)genetic pathways, interrupt the support of the microenvironment and address resistance to therapy. The Cooperation Unit between the DKFZ and the University Hospital of Ulm is ideally suited to translate molecular findings on chronic leukemia towards clinical application with respect to prognostication and therapy.

Overview of projects:

The microenvironment as a therapeutic target in chronic lymphocytic leukemia.
Ubiquitination and NOTCH1 signaling in leukemia.
Epigenetic aberrations explain leukemogenesis and help prognostication of patients.

Contact

PD Dr. Daniel Mertens

Mechanisms of Leukemogenesis (B061)

Deutsches Krebsforschungszentrum

Im Neuenheimer Feld 280

69120 Heidelberg

Tel: +49 731 500 45870

E-Mail: d.mertens@dkfz-heidelberg.de

Selected Publications

Oxidative stress as candidate therapeutic target to overcome microenvironmental protection of CLL. Yosifov DY, Idler I, Bhattacharya N, Reichenzeller M, Close V, Ezerina D, Scheffold A, Jebaraj BMC, Kugler S, Bloehdorn J, Bahlo J, Robrecht S, Eichhorst B, Fischer K, Weigel A, Busch H, Lichter P, Döhner H, Dick TP, Stilgenbauer S, Mertens D. Leukemia. 2020 Jan;34(1):115-127. doi: 10.1038/s41375-019-0513-x. Epub 2019 Jul 12. PMID: 31300746
Linking aberrant chromatin features in chronic lymphocytic leukemia to transcription factor networks. Mallm JP, Iskar M, Ishaque N, Klett LC, Kugler SJ, Muino JM, Teif VB, Poos AM, Großmann S, Erdel F, Tavernari D, Koser SD, Schumacher S, Brors B, König R, Remondini D, Vingron M, Stilgenbauer S, Lichter P, Zapatka M, Mertens D*, Rippe K*. Mol Syst Biol. 2019 May 22;15(5):e8339. doi: 10.15252/msb.20188339. PMID: 31118277
FBXW7 mutations reduce binding of NOTCH1, leading to cleaved NOTCH1 accumulation and target gene activation in CLL. Close V, Close W, Kugler SJ, Reichenzeller M, Yosifov DY, Bloehdorn J, Pan L, Tausch E, Westhoff MA, Döhner H, Stilgenbauer S, Oswald F*, Mertens D*. Blood. 2019 Feb 21;133(8):830-839. doi: 10.1182/blood-2018-09-874529. Epub 2018 Dec 3. PMID: 30510140
Comprehensive microRNA expression profiling in cerebrospinal fluid distinguishes between neurological disease classes. Grasedieck S, Mulaw M, Sperb N, Wessinger K, Rouhi A, Bommer M, Bromberg JEC, Otto M, Tumani H, von Arnim CAF, Mertens D*, Kuchenbauer F*. Neuropathol Appl Neurobiol. 2019 Apr;45(3):318-323. doi: 10.1111/nan.12491. Epub 2018 May 21. PMID: 29679382

Cookie Settings

Research

Bridging Group Mechanisms of Leukemogenesis

PD Dr. Daniel Mertens

Contact

Selected Publications